Secondary Hyperparathyroidism Treatment Market Worldwide Impressive Growth Rate and Threshold 2032 Secondary hyperparathyroidism (SHPT) is a common and serious complication of chronic kidney disease (CKD), characterized by the excessive secretion of parathyroid hormone (PTH) due to chronic renal insufficiency. This condition leads to various skeletal and cardiovascular issues, significantly impacting patients' quality of life. The growing prevalence of CKD worldwide has driven significant...
0 Поделились
333 Просмотры
0 предпросмотр